FDA Inspection 1253933 — Navin Kasliwal, Dr.
The FDA completed an inspection of Navin Kasliwal, Dr. on Oct 17, 2024 in Aurangabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 17, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Aurangabad (India)
Additional Details
Clinical BA/BE